A 40-Week Phase 2B Randomized, Multicenter, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Memantine in Amyotrophic Lateral Sclerosis
MUSCLE & NERVE(2025)
Key words
amyotrophic lateral sclerosis (ALS),biomarkers,memantine,motor neuron disease (MND),neurofilament
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined